牛血清アルブミン市場- 世界の市場規模、シェア、動向、機会、予測、製品別、用途別、地域別、競争別、2020-2030F

牛血清アルブミンの世界市場規模は2024年に56億2,000万米ドルとなり、予測期間では2030年までCAGR 8.02%で力強い成長が予測されています。

世界の牛血清アルブミン市場は、より広範なバイオテクノロジーおよび製薬業界の中で、ダイナミックかつ急速に発展している分野です。BSAは牛の血清から得られる汎用性の高いタンパク質であり、様々な科学・研究分野で幅広く応用されています。この市場には、BSAの生産、流通、利用が含まれ、学術研究機関、製薬会社、バイオテクノロジー企業、診断研究所など幅広いエンドユーザーにサービスを提供しています。例えば、国立医学図書館によると、2022年には世界で合計3億1,000万件の大手術が実施されました。このうち、米国では約4,000万～5,000万件、欧州では約2,000万件が実施されました。このことは、米国と欧州が総量のかなりの部分を占める外科手術に対する世界の需要の大きさを浮き彫りにしています。

世界の牛血清アルブミン市場の成長を牽引する主な要因としては、細胞培養や様々な生化学アッセイにおける重要な役割、様々な診断薬や治療薬における安定剤としての使用、製薬・バイオテクノロジー分野での需要の増加などが挙げられます。BSAは細胞培養培地において重要な成分として機能し、必須栄養素、成長因子、緩衝能を提供することで、細胞の成長とタンパク質の生産を促進し、バイオプロセスにおいて不可欠なものとなっています。

主要市場促進要因

バイオ医薬品産業の成長

主な市場課題

倫理的懸念と代替供給源

主要市場動向

細胞培養アプリケーションの拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の牛血清アルブミン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（ヒト血清アルブミン、ウシ血清アルブミン、組み換え血清アルブミン）
  • 用途別（治療、ドラッグデリバリー、培養培地、ワクチン成分、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 製品別
  • 用途別
  • 地域別

第5章 アジア太平洋地域の牛血清アルブミン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • 用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の牛血清アルブミン市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の牛血清アルブミン市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の牛血清アルブミン市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの牛血清アルブミン市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の牛血清アルブミン市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific
• Bio-Rad Laboratories, Inc（U.S.）
• Merck KGAA（Germany）
• Itoham Yonekyu Holdings Inc（Japan）
• Proliant Biologicals（U.S.）
• Kraeber & Co Gmbh（Germany）
• Rockland Immunochemicals Inc（U.S.）
• Rocky mountain biologicals（U.S.）
• BelHealth investment partners, LLC（U.S.）
• Bio-Techne Corporation（U.S.）

第15章 戦略的推奨

第16章 調査会社について・免責事項

Global Bovine Serum Albumin Market was valued at USD 5.62 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 8.02% through 2030. The global bovine serum albumin market is a dynamic and rapidly evolving sector within the broader biotechnology and pharmaceutical industry. Bovine serum albumin (BSA) is a versatile protein derived from cow's blood serum and has found extensive applications across various scientific and research fields. This market encompasses the production, distribution, and utilization of BSA, serving a wide range of end-users, including academic and research institutions, pharmaceutical companies, biotechnology firms, and diagnostic laboratories. For instance, according to the National Library of Medicine, a total of 310 million major surgeries were conducted worldwide in 2022. Of these, approximately 40-50 million took place in the U.S., while around 20 million were performed across Europe. This highlights the significant global demand for surgical procedures, with the U.S. and Europe comprising a substantial portion of the total volume.

Key factors driving the global bovine serum albumin market's growth include its vital role in cell culture and various biochemical assays, its use as a stabilizer in a variety of diagnostic and therapeutic products, and its increasing demand in the pharmaceutical and biotechnology sectors. BSA serves as a critical component in cell culture media, providing essential nutrients, growth factors, and buffering capacity, thereby facilitating cell growth and protein production, making it indispensable in bioprocessing.

Key Market Drivers

Growing Biopharmaceutical Industry

The rapid expansion of the biopharmaceutical industry has significantly contributed to the growth of the global bovine serum albumin (BSA) market. This burgeoning sector, driven by the development of biologics such as monoclonal antibodies, vaccines, and gene therapies, heavily relies on BSA for its unique properties and functionalities. BSA serves as a stabilizing agent during the production of biopharmaceuticals, which are complex and fragile molecules. Its ability to protect these sensitive molecules from denaturation and aggregation is crucial for ensuring the safety and efficacy of the final drug products.

The biopharmaceutical industry's increasing demand for BSA is rooted in several factors. First, the biologics market has experienced remarkable growth due to the effectiveness of these therapies in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. As more biologics enter the market and new therapies are developed, the demand for BSA as a stabilizing and protecting agent in their production processes rises correspondingly.

Key Market Challenges

Ethical Concerns and Alternative Sources

One of the primary challenges facing the BSA market is the growing ethical concern surrounding the use of bovine-derived products. The extraction of BSA from cow's blood serum is associated with ethical dilemmas, as it raises questions about the welfare of animals involved in the process. Cows may undergo invasive procedures to collect serum, raising concerns about cruelty and the treatment of these animals. In response to these concerns, consumers, organizations, and researchers are advocating for more ethical practices in the production of BSA and seeking alternatives that do not involve animal exploitation. For instance, according to a July 2022 report from the Centers for Disease Control and Prevention, six in ten Americans have at least one chronic condition, including stroke, heart disease, cancer, or diabetes. The increasing prevalence of chronic illnesses and the growing demand for personalized medicine are anticipated to drive the demand for bovine serum albumin in the region.

The ethical concerns surrounding bovine-derived BSA have driven the exploration of alternative sources of albumin. Several promising alternatives have emerged, each aiming to address ethical, sustainability, and safety issues. Two notable alternatives are recombinant albumin and plant-based albumin.

Key Market Trends

Expansion of Cell Culture Applications

The expansion of cell culture applications is a key driver boosting the global bovine serum albumin (BSA) market. Cell culture techniques have gained widespread adoption in academic research, biotechnology, and the pharmaceutical industry. BSA, derived from cow's blood serum, is an indispensable component in cell culture media, providing essential nutrients, growth factors, and buffering capacity that are critical for cell growth and protein production.

Researchers and manufacturers are increasingly relying on cell culture to propagate cells for various applications, such as drug development, vaccine production, and regenerative medicine. The ability to create a controlled environment that supports cell growth and replication is essential for the development of advanced therapies and bioprocessing. BSA plays a pivotal role in these processes, ensuring the optimal conditions for cell growth, enhancing productivity, and improving the reproducibility of experiments.

Key Market Players

• Thermo Fisher Scientific
• Bio-Rad Laboratories, Inc (U.S.)
• Merck KGAA (Germany)
• Itoham Yonekyu Holdings Inc (Japan)
• Proliant Biologicals (U.S.)
• Kraeber & Co Gmbh (Germany)
• Rockland Immunochemicals Inc (U.S.)
• Rocky mountain biologicals (U.S.)
• BelHealth investment partners, LLC (U.S.)
• Bio-Techne Corporation (U.S.)

Report Scope:

In this report, the Global Bovine Serum Albumin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bovine Serum Albumin Market, By Product:

• Human Serum Albumin
• Bovine Albumin
• Recombinant Serum Albumin

Bovine Serum Albumin Market, By Application:

• Therapeutic
• Drug Delivery
• Culture Media
• Vaccine Ingredient
• Others

Bovine Serum Albumin Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bovine Serum Albumin Market.

Available Customizations:

Global Bovine Serum Albumin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bovine Serum Albumin Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin)
  • 4.2.2. By Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient, Others)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. By Region

5. Asia Pacific Bovine Serum Albumin Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By Application
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Bovine Serum Albumin Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By Application
  • 5.3.2. India Bovine Serum Albumin Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By Application
  • 5.3.3. Australia Bovine Serum Albumin Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By Application
  • 5.3.4. Japan Bovine Serum Albumin Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By Application
  • 5.3.5. South Korea Bovine Serum Albumin Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By Application

6. Europe Bovine Serum Albumin Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Bovine Serum Albumin Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Germany Bovine Serum Albumin Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Spain Bovine Serum Albumin Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
  • 6.3.4. Italy Bovine Serum Albumin Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Application
  • 6.3.5. United Kingdom Bovine Serum Albumin Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Application

7. North America Bovine Serum Albumin Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Bovine Serum Albumin Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. Mexico Bovine Serum Albumin Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. Canada Bovine Serum Albumin Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application

8. South America Bovine Serum Albumin Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Bovine Serum Albumin Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. Argentina Bovine Serum Albumin Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Colombia Bovine Serum Albumin Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application

9. Middle East and Africa Bovine Serum Albumin Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Bovine Serum Albumin Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Saudi Arabia Bovine Serum Albumin Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. UAE Bovine Serum Albumin Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Bovine Serum Albumin Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Products
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Bio-Rad Laboratories, Inc (U.S.)
• 14.3. Merck KGAA (Germany)
• 14.4. Itoham Yonekyu Holdings Inc (Japan)
• 14.5. Proliant Biologicals (U.S.)
• 14.6. Kraeber & Co Gmbh (Germany)
• 14.7. Rockland Immunochemicals Inc (U.S.)
• 14.8. Rocky mountain biologicals (U.S.)
• 14.9. BelHealth investment partners, LLC (U.S.)
• 14.10. Bio-Techne Corporation (U.S.)

15.Startegic Recommendation

16.About Us & Disclaimer